The researchers, from Baylor College of Medicine in Houston, found that when two proteins, called AIB1 and HER-2, are present in high levels in the cells of women who have had breast cancer, their tumours are resistant to the cancer-fighting effects of tamoxifen.

BBC: Tamoxifen